Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial import inner membrane translocase subunit TIM14 (DNAJC19) is a mitochondrial co-chaperone protein located in the inner mitochondrial membrane, where it participates in the ATP-dependent import of transit peptide-containing proteins from the cytosol into the mitochondrial matrix, primarily as part of the TIM23 complex. Unlike many other DNAJ family members, TIM14’s DNAJ domain is positioned at the C-terminus, and its transmembrane domain ensures membrane localization. TIM14 also complexes with prohibitins, regulating mitochondrial morphology and cardiolipin remodeling, a lipid crucial for mitochondrial membrane integrity and function. Loss of function mutations in DNAJC19 cause dilated cardiomyopathy with ataxia (DCMA) syndrome, consisting of severe cardiac and neurological manifestations, and is associated biochemically with mitochondrial fragmentation, abnormal cristae formation, increased reactive oxygen species, and altered metabolic flux in cardiac cells. The gene is located on human chromosome 3q26.33. Diagnostic markers include elevated 3-methylglutaconic acid and evidence of mitochondrial dysfunction. As of 2024, DNAJC19 is not a direct pharmacological target, but is of substantial interest for developing approaches to mitigate mitochondrial protein import deficiencies and related pathologies.
Not applicable; no approved drugs target DNAJC19 directly, but potential mechanisms for future modulators may include stabilization of mitochondrial import, chaperone activity modulation, or rescue of mitochondrial bioenergetics
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial import inner membrane translocase subunit TIM14 (DNAJC19).